Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.44
+0.01 (0.16%)
At close: Apr 28, 2026, 4:00 PM EDT
6.32
-0.12 (-1.86%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Minerva Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cost of Revenue
5.7611.912.7114.6516.84
Upgrade
Gross Profit
-5.76-11.9-12.71-14.65-16.84
Upgrade
Selling, General & Admin
9.349.9510.4110.5813.33
Upgrade
Operating Expenses
9.349.9510.4110.5813.33
Upgrade
Operating Income
-15.1-21.85-23.12-25.23-30.17
Upgrade
Interest Expense
--4.56-8.28-7.41-6.33
Upgrade
Interest & Investment Income
0.951.271.440.560.02
Upgrade
Currency Exchange Gain (Loss)
-0.06-0-0.04-0.03-0.03
Upgrade
Other Non Operating Income (Expenses)
-279.2126.58---
Upgrade
EBT Excluding Unusual Items
-293.421.44-30.01-32.11-36.51
Upgrade
Asset Writedown
-----15.2
Upgrade
Pretax Income
-293.421.44-30.01-32.11-51.71
Upgrade
Income Tax Expense
-----1.8
Upgrade
Net Income
-293.421.44-30.01-32.11-49.91
Upgrade
Net Income to Common
-293.421.44-30.01-32.11-49.91
Upgrade
Shares Outstanding (Basic)
88755
Upgrade
Shares Outstanding (Diluted)
88755
Upgrade
Shares Change (YoY)
11.75%16.41%21.84%-4.41%
Upgrade
EPS (Basic)
-34.670.19-4.61-6.01-9.35
Upgrade
EPS (Diluted)
-34.670.19-4.61-6.01-9.35
Upgrade
Free Cash Flow
-13.51-19.55-14.78-24.66-24.6
Upgrade
Free Cash Flow Per Share
-1.60-2.58-2.27-4.62-4.61
Upgrade
EBITDA
-15.1-21.84-23.11--30.15
Upgrade
D&A For EBITDA
0.010.010.01-0.02
Upgrade
EBIT
-15.1-21.85-23.12-25.23-30.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.